StimCardio
StimCardio Medical, Inc.
StimCardio delivers innovative cardiac stimulation solutions designed to improve patient outcomes, support clinicians, and advance the future of cardiovascular care.
stimcardio.com · Los Angeles, CA
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$24.9M of $25.0M
Filed2026-07-29
Days since filing67
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2025-11-24
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Amos ZivExecutive Officer · Director
- Amir SoltianzadehExecutive Officer
- John SlumpDirector
- Tsahi HolandExecutive Officer
- Joshua PhilipsDirector
- Alexei MlodinowDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged99.8% sold10.3 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-242
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Senior QA ManagerSEP 25United States · open 9 days
- Senior Clinical Research Associate (Senior CRA)SEP 25United States · open 9 days
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.